RxDoctor Payments Data

Cortney Berkley

Psychiatric/Mental Health · Breckenridge, TXNPI 1629447859

Payments from drug & device makers

$2,423in general payments, 2019–2025

Across 129 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$749
  • AbbVie$485
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$302
  • Otsuka America Pharmaceutical, Inc.$145
  • Alkermes, Inc.$142
  • Teva Pharmaceuticals USA, Inc.$120
  • plus $480 from 12 others

What the payments were for

  • Food & beverage$2,37798%
  • Education$472%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,423 in reported general payments places this provider in the 75th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate67$577,513
VraylarCariprazine Hcl49$74,862
Invega SustennaPaliperidone Palmitate14$47,743
PerserisRisperidone15$46,055
NuedextaDextromethorphan Hbr/Quinidine22$36,393
LybalviOlanzapine/Samidorphan Malate14$22,165
Oxcarbazepine244$20,538
TrintellixVortioxetine Hydrobromide25$18,748
Chlorpromazine Hcl26$12,840
Aripiprazole176$10,758
Naltrexone Hcl89$10,450
Risperidone340$5,106
Olanzapine166$5,003
Divalproex Sodium ErDivalproex Sodium70$4,455
Lurasidone Hcl27$4,308

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$749$577,51367 claims
AbbVieVraylar$485$74,86249 claims
Johnson & JohnsonInvega Sustenna$25$47,74314 claims
Indivior Inc.Perseris$82$46,05515 claims
Avanir Pharmaceuticals, Inc.Nuedexta$89$36,39322 claims
Alkermes, Inc.Lybalvi$142$22,16514 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$59$18,74825 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Breckenridge

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →